Orchestrating
Human Response to
Autoimmune Disease

An orchestra is a divergent array of dynamic forces that converge into a beautiful result we call music…


…wind across reeds or through pipes, controlled by subtle positional changes of keys, valves, and slides; percussive strokes from snare or tympani; strings that resonate from bow or pizzicato – these all combining into a wondrous result that transforms the soul. Vibrations translated into sounds that move us through the range of human emotion, and yet, all this is impossible without the purposeful direction of a master conductor.

In the case of the immune system, the regulatory T cell (Treg) can be viewed as a conductor, powerfully directing the future course of inflammatory onslaught by its mere presence. The purpose of TregTherapeutics’ products is to create conditions that are conducive to a grand homeostatic finale. TregTherapeutics’ TILAC™ approach to tolerogenic induction is designed to create a specific environment, a tolerogenic concert hall, if you will, that enables a strong and durable outcome of restoration and healing – truly a performance worth attending.

About

Wave

TregTherapeutics is a company focused autoimmune disease and other immuno-inflammatory conditions.

Technology

Wave

Our tolerogenic approach represents a paradigm shift in the design of efficacious and sustained disease remediation.

Applications

Wave

Our technology is exceptionally versatile, encompassing a broad range of therapeutic targets and market opportunities.

Investors

Wave

TregTherapeutics’ technology platform is transformative in the truest sense
of the word.

Learn More

Would you like to take part in changing the world?
Let us explain how…